Cargando…

Ten‐year work burden after prostate cancer treatment

INTRODUCTION: We aim to characterize the magnitude of the work burden (weeks off from work) associated with prostate cancer (PCa) treatment over a 10‐year period after PCa diagnosis and identify those at greatest risk. MATERIALS AND METHODS: We identified men diagnosed with PCa treated with radical...

Descripción completa

Detalles Bibliográficos
Autores principales: Washington, Samuel L., Lonergan, Peter E., Cowan, Janet E., Zhao, Shoujun, Broering, Jeanette M., Palmer, Nynikka R., Hicks, Cameron, Cooperberg, Matthew R., Carroll, Peter R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557888/
https://www.ncbi.nlm.nih.gov/pubmed/37724617
http://dx.doi.org/10.1002/cam4.6530
_version_ 1785117170083037184
author Washington, Samuel L.
Lonergan, Peter E.
Cowan, Janet E.
Zhao, Shoujun
Broering, Jeanette M.
Palmer, Nynikka R.
Hicks, Cameron
Cooperberg, Matthew R.
Carroll, Peter R.
author_facet Washington, Samuel L.
Lonergan, Peter E.
Cowan, Janet E.
Zhao, Shoujun
Broering, Jeanette M.
Palmer, Nynikka R.
Hicks, Cameron
Cooperberg, Matthew R.
Carroll, Peter R.
author_sort Washington, Samuel L.
collection PubMed
description INTRODUCTION: We aim to characterize the magnitude of the work burden (weeks off from work) associated with prostate cancer (PCa) treatment over a 10‐year period after PCa diagnosis and identify those at greatest risk. MATERIALS AND METHODS: We identified men diagnosed with PCa treated with radical prostatectomy, radiation therapy, or active surveillance/watchful waiting within CaPSURE. Patients self‐reported work burden and SF36 general health scores via surveys before and 1,3,5, and 10 years after treatment. Using multivariate repeated measures generalized estimating equation modeling we examined the association between primary treatment with risk of any work weeks lost due to care. RESULTS: In total, 6693 men were included. The majority were White (81%, 5% Black, and 14% Other) with CAPRA low‐ (60%) or intermediate‐risk (32%) disease and underwent surgery (62%) compared to 29% radiation and 9% active surveillance. Compared to other treatments, surgical patients were more likely to report greater than 7 days off work in the first year, with relatively less time off over time. Black men (RR 0.64, 95% CI 0.54–0.77) and those undergoing radiation (vs. surgery, RR 0.46, 95% CI 0.41–0.51) were less likely to report time off from work over time. Mean baseline GH score (73 [SD 18]) was similar between race and treatment groups, and stable over time. CONCLUSIONS: The work burden of cancer care continued up to 10 years after treatment and varied across racial groups and primary treatment groups, highlighting the multifactorial nature of this issue and the call to leverage greater resources for those at greatest risk.
format Online
Article
Text
id pubmed-10557888
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105578882023-10-07 Ten‐year work burden after prostate cancer treatment Washington, Samuel L. Lonergan, Peter E. Cowan, Janet E. Zhao, Shoujun Broering, Jeanette M. Palmer, Nynikka R. Hicks, Cameron Cooperberg, Matthew R. Carroll, Peter R. Cancer Med RESEARCH ARTICLES INTRODUCTION: We aim to characterize the magnitude of the work burden (weeks off from work) associated with prostate cancer (PCa) treatment over a 10‐year period after PCa diagnosis and identify those at greatest risk. MATERIALS AND METHODS: We identified men diagnosed with PCa treated with radical prostatectomy, radiation therapy, or active surveillance/watchful waiting within CaPSURE. Patients self‐reported work burden and SF36 general health scores via surveys before and 1,3,5, and 10 years after treatment. Using multivariate repeated measures generalized estimating equation modeling we examined the association between primary treatment with risk of any work weeks lost due to care. RESULTS: In total, 6693 men were included. The majority were White (81%, 5% Black, and 14% Other) with CAPRA low‐ (60%) or intermediate‐risk (32%) disease and underwent surgery (62%) compared to 29% radiation and 9% active surveillance. Compared to other treatments, surgical patients were more likely to report greater than 7 days off work in the first year, with relatively less time off over time. Black men (RR 0.64, 95% CI 0.54–0.77) and those undergoing radiation (vs. surgery, RR 0.46, 95% CI 0.41–0.51) were less likely to report time off from work over time. Mean baseline GH score (73 [SD 18]) was similar between race and treatment groups, and stable over time. CONCLUSIONS: The work burden of cancer care continued up to 10 years after treatment and varied across racial groups and primary treatment groups, highlighting the multifactorial nature of this issue and the call to leverage greater resources for those at greatest risk. John Wiley and Sons Inc. 2023-09-19 /pmc/articles/PMC10557888/ /pubmed/37724617 http://dx.doi.org/10.1002/cam4.6530 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle RESEARCH ARTICLES
Washington, Samuel L.
Lonergan, Peter E.
Cowan, Janet E.
Zhao, Shoujun
Broering, Jeanette M.
Palmer, Nynikka R.
Hicks, Cameron
Cooperberg, Matthew R.
Carroll, Peter R.
Ten‐year work burden after prostate cancer treatment
title Ten‐year work burden after prostate cancer treatment
title_full Ten‐year work burden after prostate cancer treatment
title_fullStr Ten‐year work burden after prostate cancer treatment
title_full_unstemmed Ten‐year work burden after prostate cancer treatment
title_short Ten‐year work burden after prostate cancer treatment
title_sort ten‐year work burden after prostate cancer treatment
topic RESEARCH ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557888/
https://www.ncbi.nlm.nih.gov/pubmed/37724617
http://dx.doi.org/10.1002/cam4.6530
work_keys_str_mv AT washingtonsamuell tenyearworkburdenafterprostatecancertreatment
AT lonerganpetere tenyearworkburdenafterprostatecancertreatment
AT cowanjanete tenyearworkburdenafterprostatecancertreatment
AT zhaoshoujun tenyearworkburdenafterprostatecancertreatment
AT broeringjeanettem tenyearworkburdenafterprostatecancertreatment
AT palmernynikkar tenyearworkburdenafterprostatecancertreatment
AT hickscameron tenyearworkburdenafterprostatecancertreatment
AT cooperbergmatthewr tenyearworkburdenafterprostatecancertreatment
AT carrollpeterr tenyearworkburdenafterprostatecancertreatment